[Myelin oligodendrocyte glycoprotein antibody-associated disease].

Authors

Malene Landbo Børresen, Jeppe Romme Christensen, Karen Markussen Linnet, Christine Nilsson, Viktoria Papp, Kristina Bacher Svendsen, Zsolt Illes

Published in

Ugeskrift for laeger. Volume 188. Issue 37. Sep 07, 2026. Epub Sep 07, 2026.

Abstract

MOG-antibody-associated disease (MOGAD) is a rare inflammatory demyelinating CNS condition. Diagnosis is based on core clinical symptoms supported by additional clinical/MRI data if necessary, depending on the antibody titer in the blood. The clinical presentation is age-dependent. Due to its recent recognition, management is not clearly defined. Treatment differs from other inflammatory demyelinating CNS diseases such as multiple sclerosis (MS) or neuromyelitis optica spectrum disorder (NMOSD) despite overlapping symptoms. In this review, we summarise recent knowledge for optimal patient management.

PMID:
42746943
Bibliographic data and abstract were imported from PubMed on 16 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.